New Vaccine Technologies to Combat Outbreak Situations

Summary: The study presented encouraging data on a DNA vaccine against Zika virus infection in a phase 1 clinical trial. The vaccine elicited anti-ZIKV immune responses with no serious adverse events reported at the interim analysis. Further studies are needed to evaluate the safety and efficacy of the vaccine.